2025 SUPPORTERS
DIAMOND ELITE SPONSOR
The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) is an inclusive global network of scientists, clinicians and dementia professionals. Members of this professional organization share common goals: the pursuit of knowledge, collaboration and breakthroughs to advance the research and treatment of Alzheimer’s disease and other dementias.
PALLADIUM SPONSORS
For more than 65 years, Lantheus has been advancing patient care by learning, adapting and making advancements across the healthcare spectrum. We’ve been an instrumental pioneer in the field of medical imaging and, today, we’re reaching further still with novel therapeutics and AI technologies. And we’ll continue to forge ahead with new solutions to new problems—always knowing that someone’s health is in our hands.
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe.
Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
GOLD SPONSORS
The Eisai Group’s Corporate Concept is “to give first thought to patients and the people in the daily living domain, and to increase the benefits that health care provides to them”.
Toronto based Enigma Biomedical Group (EBG) enhances access to key technologies with a focus on molecular imaging and medicine. EBG offers a suite of services to the pharmaceutical industry and clinical research community to accelerate drug development and global access. EBG partners with academic institutions and universities to foster and broaden access to novel research
SILVER + SCHOLARSHIP SPONSORS
The Rainwater Charitable Foundation (RCF) was created in the early 1990s by renowned private equity investor and philanthropist Richard E. Rainwater. When Richard was diagnosed with a rare neurodegenerative disease and primary tauopathy called Progressive Supranuclear Palsy (PSP), the RCF expanded its mission to accelerate the development of new diagnostics and treatments for tau-related neurodegenerative disorders. The RCF Medical Research Team supports this focus by managing the Tau Consortium, the Rainwater Prize Program and the Tauopathy Challenge Workshop. With over $140 million invested in medical research to date, the RCF has helped to advance eight treatments into human trials. Currently the RCF supports a range of programs, including a focus on family economic security, medical research and other worthy causes. For more information, please visit rainwatercharitablefoundation.org.
 |
 |
SILVER SPONSORS
Life Molecular Imaging’s mission is to develop novel PET tracers in the field of molecular imaging that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.
XingImaging is a neuroimaging services company specializing in the efficient application of scintigraphic biomarkers in drug development and clinical research for neurodegenerative and neuropsychiatric disorders.
BRONZE SPONSORS
C₂N Diagnostics is a molecular diagnostics company aiming to transform the early diagnosis and early treatment of Alzheimer’s disease and related forms of neurodegeneration
Powering precision proteomics with unrivaled sensitivity and simplicity.
Developing and commercializing novel diagnostics for Alzheimer’s disease and related forms of neurodegeneration to improve treatment decisions and patients’ lives
As a stand-alone company, GE HealthCare is a leader in precision care, infusing innovation with patient-focused technologies to enable better care.
Fujirebio is an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care.
We’re incredibly passionate about the work we are doing, and wholeheartedly believe that we can transform today’s sick care into tomorrow’s precision healthcare through early detection and disease prevention sciences.
We’re on course to transform the practice of medicine through breakthrough science and make a positive impact on our people and the communities we serve.